← Back to home

Conditions Directory

Start with the outcome. Then choose interventions.

Each condition profile maps top interventions, evidence confidence, and where supplements fit within full-stack clinical strategy.

107 conditions mapped

How to Read Evidence and Risk

These labels are directional research signals, not medical advice. Use them to compare options faster, then validate decisions with a qualified clinician.

Evidence Levels

  • A: Multiple strong human datasets with repeatable outcomes.
  • B: Promising human evidence, but endpoint quality/consistency still evolving.
  • C: Early or translational evidence; use exploratory caution.

Risk Levels

  • Low Risk: Generally well-tolerated in common protocols.
  • Moderate Risk: Potential interactions or dose sensitivity; monitor use.
  • Needs Monitoring: Physician-guided only; labs and clinical oversight expected.

Condition Strategy

GradeB

Circadian Rhythm Disruption

Restore circadian alignment to reduce metabolic, cognitive, and aging consequences

Guidance

Circadian disruption from irregular sleep, shift work, or artificial light exposure is linked to metabolic disease, accelerated aging, and cognitive impairment. Light hygiene and consistent timing are first-line interventions.

Top steps

consistent sleep-wake timing • morning bright light exposure • evening light restriction

Mentioned in 3 articles

Open profile

Condition Strategy

GradeA

Hyperlipidemia and Dyslipidemia

Optimize lipid profile to reduce cardiovascular disease risk

Guidance

Lifestyle modification is first-line for dyslipidemia. Statins have the strongest evidence for cardiovascular risk reduction. Natural approaches (omega-3, plant sterols, soluble fiber) provide meaningful adjunctive support.

Top steps

dietary modification (reduce saturated fat, increase soluble fiber) • physical activity • statin therapy when indicated

Mentioned in 2 articles

Open profile

Condition Strategy

GradeB

Non-Alcoholic Fatty Liver Disease (MASLD)

Reduce hepatic steatosis and prevent progression to fibrosis and cirrhosis

Guidance

MASLD affects approximately 25% of adults globally. Weight loss of 7-10% reduces hepatic steatosis significantly. Supplements including berberine and silymarin show consistent liver enzyme improvement.

Top steps

caloric deficit (7-10% weight loss) • aerobic and resistance exercise • low-fructose dietary modification

Mentioned in 2 articles

Open profile

Condition Strategy

GradeA

Obesity and Excess Adiposity

Achieve and maintain healthy body composition to reduce metabolic and cardiovascular risk

Guidance

Obesity drives insulin resistance, inflammation, and accelerated aging. Modest weight loss (5-10%) produces disproportionate improvements in metabolic risk. Supplement support is adjunctive at best.

Top steps

sustained caloric deficit • high-protein diet for satiety and muscle preservation • resistance and aerobic exercise

Mentioned in 2 articles

Open profile

Condition Strategy

GradeA

Osteoporosis and Bone Density Decline

Prevent fractures by maintaining bone density above fracture threshold

Guidance

Bone density peaks in the late 20s and declines progressively. Weight-bearing exercise, adequate calcium, vitamin D3, and vitamin K2 form the evidence-based prevention foundation. Bisphosphonates are indicated for established osteoporosis.

Top steps

weight-bearing exercise • adequate calcium intake • vitamin D3 optimization

Mentioned in 6 articles

Open profile

Condition Strategy

GradeB

Thyroid Dysfunction

Maintain optimal thyroid function and prevent progression of subclinical disease

Guidance

Thyroid function is sensitive to selenium, iodine, and zinc status. Selenium supplementation reduces thyroid antibody levels in Hashimoto's thyroiditis. Subclinical hypothyroidism often requires monitoring rather than immediate treatment.

Top steps

selenium supplementation for autoimmune thyroiditis • iodine adequacy • zinc optimization

Mentioned in 1 article

Open profile

Condition Strategy

GradeA

Chronic Kidney Disease

Slow GFR decline, manage cardiovascular risk, and prevent acute kidney injury

Guidance

CKD progression is driven by hypertension, diabetes, and chronic inflammation. Blood pressure control and avoiding nephrotoxic agents (including high-dose oxalate supplements and aristolochic acid) are the primary levers. Omega-3 and potassium citrate have supportive roles in specific contexts.

Top steps

blood pressure control to <130/80 mmHg • protein intake moderation in advanced CKD • sodium restriction

Mentioned in 2 articles

Open profile

Condition Strategy

GradeB

Low Testosterone and Andropause

Restore testosterone to functional range, preserve muscle mass and cognitive vitality

Guidance

Testosterone declines ~1% per year after age 30 in men. Lifestyle interventions — particularly resistance training, sleep, and correcting nutrient deficiencies (zinc, vitamin D) — are first-line. Ashwagandha and fenugreek show modest RCT support. TRT is indicated when levels fall below clinical thresholds with symptoms.

Top steps

progressive resistance training • sleep optimization (7-9 hours) • body fat reduction

Mentioned in 2 articles

Open profile